Home › Cerebral Hemorrhage › Massachusetts › Boston
Cerebral Hemorrhage clinical trials in Boston, MA
6 studies for Cerebral Hemorrhage are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
Recruiting
- Beth Israel Deaconess Medical Center, Boston
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RecruitingObservational study
- Massachusetts General Hospital, Boston
- Boston Medical Center, Boston
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RecruitingPhase 3
- Massachusetts General Hospital, Boston
Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors
Recruiting
- Massachusetts General Hospital, Boston
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Boston Medical Center, Boston
- and 1 more
Statins In Intracerbral Hemorrhage
RecruitingPhase 3
- Beth Israel Deaconess Medical Center, Boston
Cerebral Hemorrhage trials in other cities
- New York City, NY8 studies
- Miami, FL7 studies
- Chicago, IL6 studies
- Philadelphia, PA6 studies
- Columbus, OH5 studies
- St. Louis, MO5 studies
- Baltimore, MD4 studies
- Jacksonville, FL4 studies
- Atlanta, GA4 studies
- Nashville, TN4 studies
- Columbia, MO4 studies
- The Bronx, NY4 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.